Continuous Bioprocessing Market
The global continuous bioprocessing market size was valued at USD 174.40 million in 2024 and is expected to reach USD 670.83 million by 2032, at a CAGR of 18.34% during the forecast period The market growth is largely fueled by the increasing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and cell and gene therapies, driving adoption of more efficient manufacturing processes Furthermore, advancements in technologies such as single-use systems, real-time monitoring, and process analytical technology (PAT) are enhancing productivity, reducing operational costs, and improving process control, thereby accelerating the uptake of continuous bioprocessing solutions and significantly boosting the industry's growth https://www.databridgemarketresearch.com/reports/global-continuous-bioprocessing-market